Lilly Endowment plans to sell 295,000 Lilly shares and has reduced its holding since August. These are the holder's shares, and the report names no change to Lilly's business or finances, so its outlook is unchanged.
The shares belong to Lilly Endowment, so the planned sale does not put money into or take money from Lilly. Earlier reductions may affect how people view the stock, but the report names no change to Lilly's products, sales, or finances.
Follow Eli Lilly and Company (LLY) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for LLY